SCHEMBL8002138

SCHEMBL8002138

CCOc1cc(N)c(Br)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HPGD P15428 2/20 0.44
POLB P06746 2/20 0.44
MAPK1 P28482 1/20 0.44
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
USP2 O75604 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
CREBBP Q92793 1/20 0.38
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31714447 0.86 ALDH1A1 (0.46) HSD17B10ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL21616261 0.86 ALDH1A1 (0.48) HSD17B10ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL18464138 0.84 CYP1A2 (0.47) ALDH1A1MAPTL3MBTL1KDM4EMEN1
SCHEMBL11652171 0.84 ALDH1A1 (0.50) HSD17B10ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL23586503 0.82 TSHR (0.46) HSD17B10ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL653555 0.82 ALDH1A1 (0.48) HSD17B10ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL3347814 0.80 LOX (0.37) ALDH1A1MAPTL3MBTL1KDM4EPOLB
SCHEMBL4568234 0.79 HSD17B10 (0.43) HSD17B10ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL11653686 0.78 ALDH1A1 (0.53) HSD17B10ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL19777817 0.78 LMNA (0.48) HSD17B10ALDH1A1MAPTL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256114-B1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAINIPPON SUMITOMO PHARMA CO (JP) 2014-06-25 EP disclosed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US disclosed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US disclosed
EP-2256114-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Dainippon Sumitomo Pharma Co., Ltd. (JP) 2010-12-01 EP disclosed
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Sumitomo Pharma Co., Ltd. (JP) 2010-09-30 US disclosed
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Sumitomo Pharma Co., Ltd. (JP) 2010-09-30 US disclosed
WO-2009104729-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 大日本住友製薬株式会社 (JP) 2009-08-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME HTR4, MC2R, HTR1D HSD17B10 1608/4885ALDH1A1 2118/4885MAPT 3278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.